Jianping Wang

Title: Innovations of Jianping Wang in Pharmaceutical Crystallization

Introduction

Jianping Wang is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of pharmaceutical sciences, particularly in the area of drug crystallization. His innovative approaches have the potential to enhance the safety and efficiency of medication production.

Latest Patents

One of Jianping Wang's key patents is titled "Crystal form F of trelagliptin and preparation method thereof." This patent describes a method for preparing a novel crystal form F of trelagliptin. The process involves adding a mediating protein to trelagliptin to create a mixture, followed by applying mechanochemical action to transform the crystal form. This method is advantageous as it does not require organic solvents, thereby eliminating the risk of solvent residues that could compromise medication safety. Additionally, the preparation method is less time-consuming than traditional solvent crystallization methods, making it suitable for green industrial production. It is characterized by simplicity, high efficiency, safety, and environmental friendliness.

Career Highlights

Jianping Wang is affiliated with the Guangdong University of Technology, where he continues to engage in research and development in the field of pharmaceutical sciences. His work has garnered attention for its innovative approach to drug formulation and production.

Collaborations

Jianping Wang collaborates with esteemed colleagues, including Shungquan Mu and Kailin Xu, who contribute to his research endeavors. Their combined expertise enhances the quality and impact of their work in the field.

Conclusion

Jianping Wang's contributions to pharmaceutical crystallization exemplify the importance of innovation in enhancing drug safety and production efficiency. His work not only advances scientific knowledge but also has practical implications for the pharmaceutical industry.